X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-26 | TSVT | Casdin Capital, LLC | Dir | P - Purchase | $5.10 | +40,000 | 2,016,600 | +2% | +$203,992 | ||||||
| DM | 2024-03-21 | TSVT | Casdin Capital, LLC | Dir | P - Purchase | $5.02 | +777,377 | 1,976,600 | +65% | +$3,899,050 | |||||
| D | 2024-01-05 | TSVT | Baird William D III | COO | S - Sale+OE | $3.75 | -1,380 | 252,335 | -1% | -$5,180 | |||||
| D | 2024-01-05 | TSVT | Gregory Philip D | Chief Scientific Officer | S - Sale+OE | $3.75 | -795 | 310,280 | 0% | -$2,984 | |||||
| D | 2024-01-05 | TSVT | Leschly Nick | Pres, CEO | S - Sale+OE | $3.75 | -1,554 | 1,376,709 | 0% | -$5,833 | |||||
2024-01-03 | TSVT | Leschly Nick | Pres, CEO | S - Sale | $3.87 | -72,312 | 1,143,263 | -6% | -$279,739 | ||||||
2024-01-03 | TSVT | Gregory Philip D | Chief Scientific Officer | S - Sale | $3.87 | -25,613 | 231,637 | -10% | -$99,084 | ||||||
2024-01-03 | TSVT | Baird William D III | COO | S - Sale | $3.87 | -33,651 | 162,715 | -17% | -$130,179 | ||||||
2023-08-22 | TSVT | Leschly Nick | Pres, CEO | S - Sale | $5.49 | -9,312 | 1,215,575 | -1% | -$51,090 | ||||||
2023-08-22 | TSVT | Gregory Philip D | Chief Scientific Officer | S - Sale | $5.49 | -6,159 | 257,250 | -2% | -$33,791 | ||||||
2023-08-22 | TSVT | Baird William D III | CFO | S - Sale | $5.49 | -7,031 | 196,366 | -3% | -$38,576 | ||||||
2023-08-10 | TSVT | Kynam Global Healthcare Master Fund, LP | 10% | P - Purchase | $5.92 | +601,828 | 10,284,222 | +6% | +$3,564,315 | ||||||
2023-08-10 | TSVT | Kynam Capital Management, LP | 10% | P - Purchase | $5.92 | +601,828 | 10,284,222 | +6% | +$3,564,315 | ||||||
2023-08-03 | TSVT | Leschly Nick | Pres, CEO | S - Sale | $6.13 | -9,060 | 1,224,887 | -1% | -$55,499 | ||||||
2023-08-03 | TSVT | Gregory Philip D | Chief Scientific Officer | S - Sale | $6.13 | -3,966 | 263,409 | -1% | -$24,295 | ||||||
2023-08-03 | TSVT | Baird William D III | CFO | S - Sale | $6.13 | -6,906 | 203,397 | -3% | -$42,304 | ||||||
2023-02-13 | TSVT | Baird William D III | CFO | S - Sale | $12.86 | -637 | 210,303 | 0% | -$8,192 | ||||||
2023-02-07 | TSVT | Heffron Nicola | COO | S - Sale | $14.70 | -60 | 89,182 | 0% | -$882 | ||||||
2023-01-11 | TSVT | Gregory Philip D | Chief Scientific Officer | S - Sale | $10.63 | -1,076 | 99,518 | -1% | -$11,436 | ||||||
2023-01-11 | TSVT | Heffron Nicola | COO | S - Sale | $10.63 | -128 | 89,242 | 0% | -$1,360 | ||||||
2023-01-11 | TSVT | Leschly Nick | Pres, CEO | S - Sale | $10.63 | -2,026 | 590,626 | 0% | -$21,533 | ||||||
2023-01-11 | TSVT | Baird William D III | CFO | S - Sale | $10.63 | -1,077 | 78,797 | -1% | -$11,446 | ||||||
2023-01-12 | TSVT | Leschly Nick | Pres, CEO | S - Sale | $10.46 | -6,587 | 592,652 | -1% | -$68,889 | ||||||
2023-01-09 | TSVT | Heffron Nicola | COO | S - Sale | $10.33 | -584 | 89,370 | -1% | -$6,035 | ||||||
2023-01-09 | TSVT | Gregory Philip D | Chief Scientific Officer | S - Sale | $10.33 | -3,794 | 100,594 | -4% | -$39,210 | ||||||
2023-01-09 | TSVT | Baird William D III | CFO | S - Sale | $10.33 | -3,222 | 79,874 | -4% | -$33,298 | ||||||
2023-01-09 | TSVT | Leschly Nick | Pres, CEO | S - Sale | $10.33 | -2,979 | 599,239 | 0% | -$30,787 | ||||||
2022-12-05 | TSVT | Heffron Nicola | COO | S - Sale | $15.43 | -272 | 89,954 | 0% | -$4,198 | ||||||
2022-11-21 | TSVT | Heffron Nicola | COO | S - Sale | $13.97 | -7,697 | 90,226 | -8% | -$107,527 | ||||||
2022-08-05 | TSVT | Baird William D III | CFO | S - Sale | $16.23 | -4,152 | 83,096 | -5% | -$67,397 | ||||||
2022-08-05 | TSVT | Gregory Philip D | Chief Scientific Officer | S - Sale | $16.23 | -2,407 | 104,388 | -2% | -$39,072 | ||||||
2022-08-05 | TSVT | Leschly Nick | Pres, CEO | S - Sale | $16.23 | -5,499 | 602,218 | -1% | -$89,263 | ||||||
2022-07-15 | TSVT | Baird William D III | CFO | S - Sale | $13.81 | -4,080 | 87,248 | -4% | -$56,344 | ||||||
2022-07-15 | TSVT | Gregory Philip D | Chief Scientific Officer | S - Sale | $13.81 | -2,365 | 106,795 | -2% | -$32,660 | ||||||
2022-07-15 | TSVT | Leschly Nick | Pres, CEO | S - Sale | $13.81 | -5,404 | 607,717 | -1% | -$74,629 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |